Description
About
Chitrakathriphaladi Kashaya Choornam is a classical Ayurvedic powder formulation used to prepare herbal decoction (Kashayam). It combines the digestive and metabolism-boosting power of Chitraka (Plumbago zeylanica) with the detoxifying and rejuvenating qualities of Triphala (Haritaki, Bibhitaki, Amalaki). This choornam is primarily prescribed for digestive ailments, obesity, liver disorders, and skin diseases.
Uses
-
Indigestion, loss of appetite, and bloating
-
Constipation and sluggish digestion
-
Obesity and metabolic disorders
-
Liver and spleen disorders
-
Skin diseases caused by toxin accumulation
-
General detox and digestive strengthening
Benefits
-
Improves digestion and metabolism
-
Acts as a mild purgative and detoxifier
-
Reduces Ama (toxins) and clears channels
-
Promotes healthy liver and spleen function
-
Supports weight management by balancing Kapha
-
Enhances skin health by purifying blood
Different Names in Different Languages
-
Sanskrit: Chitrakathriphaladi Kashaya Choornam
-
Tamil: சித்ரக திரிபலாதி கஷாயச் சூரணம்
-
Hindi: चित्रक त्रिफला काढ़ा चूर्ण
-
Telugu: చిత్రక త్రిఫలాది కషాయ చూర్ణం
-
Kannada: ಚಿತ್ರಕ ತ್ರಿಫಲಾದಿ ಕಷಾಯ ಚೂರ್ಣ
-
Malayalam: ചിത്രക ത്രിഫലാദി കശായ ചൂർണം
-
English: Chitrak Triphala Kashaya Powder
Key Ingredients
-
Chitraka (Plumbago zeylanica) – Improves digestion, reduces fat, stimulates metabolism
-
Triphala (Haritaki, Vibhitaki, Amalaki) – Detoxifying, rejuvenating, supports digestion and skin health
-
Other supportive herbs (based on classical text reference)
Dosage & Administration
-
Kashayam preparation:
-
Boil 5–10 g of choornam in 200 ml water, reduce to 50 ml, and strain.
-
-
Adults: 10–15 ml twice daily, or as directed by the physician
-
Children: Dose to be decided by an Ayurvedic doctor
-
Best taken before food
Precautions
-
Should be taken under medical supervision
-
Not recommended in pregnancy or for people with ulcerative conditions
-
Excess dosage may cause loose motions
-
Store in a cool, dry place

























Reviews
There are no reviews yet.